CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $59,991,980
- in 20 filings, $60.0M under 10b5-1 plans
Net −$59,991,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 82 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-18 | Anders Jack Chief Financial Officer | Sale | −1,427 | $31.31 | $45K | 53,667 |
| 2023-09-18 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −2,514 | $31.31 | $79K | 96,960 |
| 2023-09-15 | Horn Margaret A Chief Operating Officer | Exercise or conversion 10b5-1 | +5,000 | $4.09 | $20K | 104,474 |
| 2023-09-15 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −5,000 | $32.08 | $160K | 99,474 |
| 2023-09-15 | Horn Margaret A Chief Operating Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,000 | 103,302 | ||
| 2023-09-01 | GOLDSMITH MARK A Director | Exercise or conversion | +17,993 | $0.54 | $10K | 375,379 |
| 2023-09-01 | GOLDSMITH MARK A Director | Exercise or conversion | +12,007 | $1.12 | $13K | 387,386 |
| 2023-09-01 | GOLDSMITH MARK A Director | Sale | −30,000 | $35.05 | $1.1M | 357,386 |
| 2023-09-01 | GOLDSMITH MARK A Director | Sale | −5,000 | $35.04 | $175K | 35,424 |
| 2023-09-01 | GOLDSMITH MARK A Director | Sale | −5,000 | $35.04 | $175K | 35,424 |
| 2023-09-01 | GOLDSMITH MARK A Director | Exercise or conversion · Stock Option (Right to Buy) | −17,993 | 205,503 | ||
| 2023-09-01 | GOLDSMITH MARK A Director | Exercise or conversion · Stock Option (Right to Buy) | −12,007 | 46,479 | ||
| 2023-09-01 | Weber Barbara Director | Exercise or conversion | +3,854 | $1.12 | $4K | 19,679 |
| 2023-09-01 | Weber Barbara Director | Exercise or conversion | +11,146 | $4.73 | $53K | 30,825 |
| 2023-09-01 | Weber Barbara Director | Sale | −15,000 | $35.07 | $526K | 15,825 |
| 2023-09-01 | Weber Barbara Director | Exercise or conversion · Stock Option (Right to Buy) | −3,854 | 9,635 | ||
| 2023-09-01 | Weber Barbara Director | Exercise or conversion · Stock Option (Right to Buy) | −11,146 | 1,851 | ||
| 2023-09-01 | Anders Jack Chief Financial Officer | Exercise or conversion 10b5-1 | +20,000 | $2.68 | $54K | 75,094 |
| 2023-09-01 | Anders Jack Chief Financial Officer | Sale 10b5-1 | −20,000 | $35.05 | $701K | 55,094 |
| 2023-09-01 | Anders Jack Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −20,000 | 42,201 |
Page 31 of 39 · 775 trades